You searched for Humanized antibody - Page 9 of 44

News and Trends 22 Nov 2022

CatalYm raises €50M to boost solid tumors trial

…GDFATHER-2 trial (GDF-15 antibody-mediated human effector cell relocation phase 2). The study evaluates visugromab in combination with an anti-PD1 antibody in patients with advanced solid tumors that are relapsed/refractory to…

November 22, 2022 - 2 minutesmins - By Jim Cornall

Best in Biotech 30 Apr 2018

The 5 Best-Selling European Drugs of 2017

…be interesting! 2. Avastin (bevacizumab) Producer: Genentech (Roche) 2017 revenue: €5.6 billion 8th best-selling drug globally Bevacizumab is a recombinant humanized monoclonal antibody and the first angiogenesis inhibitor to be…

April 30, 2018 - 7 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 3 Oct 2022

Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo

…condition has been met. About auremolimab Auremolimab (VM6) is a novel, ultra-humanized, anti-IL-15Rβ (CD122) antibody designed to target and deplete autoreactive resident memory T cells (TRM) that has demonstrated efficacy…

October 3, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 19 Feb 2018

This Belgian Biotech Gives Us an Update on its Bulging Psoriasis Pipeline

…delivered systemically. UCB’s bimekizumab is a humanized monoclonal IgG1 antibody that neutralizes both IL-17A and IL-17F, two key inflammatory cytokines. In preclinical studies, the drug was better at reducing skin…

February 19, 2018 - 3 minutesmins - By Alex Dale

News and Trends 31 Aug 2022

Emactuzumab designated as an orphan medicinal product for TGCT in Europe

…function of these cells. Emactuzumab is a humanized IgG1 CSF-1R targeted antibody that inhibits and depletes macrophages in the tumor tissue. Emactuzumab was originally discovered and developed by Roche and…

August 31, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 5 Oct 2016

New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira

New results from a Phase III trial show that guselkumab, an antibody therapy for the autoimmune disease plaque psoriasis, is performing better than the number one best-seller drug Humira (adalimumab)…

October 5, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Sep 2017

FREE TICKET Giveaway – European Antibody Congress

Our wonderful readers now have the chance to win a FREE ticket for the European Antibody Congress in Basel, Switzerland! On 31st October – 2nd November you will have the…

September 5, 2017 - 2 minutesmins - By External Contributor

News and Trends 30 Jun 2020

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody drug patents held by US giant Regeneron, a decision that could make it harder for…

June 30, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 30 Jan 2018

Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid tumors. Innate Pharma uses antibodies to enhance the immune…

January 30, 2018 - 3 minutesmins - By Alex Dale

News and Trends 25 Sep 2017

Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains

…powerful ‘tri-specific antibody’. Structure of the HIV virus. Sanofi’s tri-antibody treatment targets the synthesis of the phospholipid envelope. Current treatments are based on the use of antiretroviral therapy (ART), which…

September 25, 2017 - 3 minutesmins - By Alex Dale

News and Trends 16 Nov 2016

New Private Placement to Boost the Profitable Therapeutic Antibody Market

MorphoSys has announced a private placement of shares to raise funds for its antibody therapy programs. With this push, the company is solidifying its position as a leader in the…

November 16, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 2 Jul 2024

Swiss biotech going strong in 2024: 18 companies to put on your radar

…as a monotherapy and in combination with pembrolizumab, an anti-PD-1 antibody. The company’s most advanced program is Lixudebart (ALE.F02). It is a monoclonal antibody designed to treat organ fibrosis and…

July 2, 2024 - 20 minutesmins - By Jules Adam

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

CatalYm raises €50M to boost solid tumors trial

The 5 Best-Selling European Drugs of 2017

Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo

This Belgian Biotech Gives Us an Update on its Bulging Psoriasis Pipeline

Emactuzumab designated as an orphan medicinal product for TGCT in Europe

New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira

FREE TICKET Giveaway – European Antibody Congress

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains

New Private Placement to Boost the Profitable Therapeutic Antibody Market

Swiss biotech going strong in 2024: 18 companies to put on your radar

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!